MedPath

A Clinical Study on Combined Effectiveness of Oral and Topical Application of an Ayurvedic Medicine - Agastya Ghrita in the Management of Retinitis Pigmentosa

Phase 2
Recruiting
Conditions
Shleshma vidagdha Drishti( Retinitis pigmentosa)
Registration Number
CTRI/2017/05/008552
Lead Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Brief Summary

This study is a non randomized single arm clinical trial assessing the effectiveness of Agastya ghrita pana and Tarpana in the management of Shleshmavidagdha Drishti( Retinitis pigmentosa). 30 patients will be enrolled for this study for one month.This study period will be  one and half year.The primary outcome measures will be reduction of night blindness, reduction of peripheral visual field loss and blurredness of vision. The secondary out come will be controls of  the further deterioration of night blindness, reduced peripheral visual field and blurredness of vision. Baseline data will be assessed after the treatment and in first follow up after treatment i.e 45th and 60th day of treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patient ready to sign in informed consent form irrespective of sex, and religion.
  • Naktandhata (night blindness) 2.
  • Difficulty in dark adaptation 3.
  • Reduced field of vision 4.Blurredness of vision 5.Visual acuity test revealing reduced visual acuity.
  • 6.Perimetry showing peripheral visual field defect 7.
  • Opthalamoscopic evaluation of Fundus revealing classical triad of Retinitis pigmentosa (arteriolar attenuation, retinal bone-spicule pigmentation and waxy pallor).
  • Pictorial assessment of Retinitis pigmentosa through Fundal photograph.
Exclusion Criteria
  • 1.Patients having total blindness.
  • 2.Patient with all kind of diabetic retinopathy and diabetic maculopathy.
  • 3.Patient with pregnancy and lactating period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity test revealing visual acuity improving1 month
Improvement in nightblindness1 month
improvement in dark adaptation1 month
improvement of field of vision1 month
Perimetry showing peripheral visual field changes1 month
Fundal pictorial changes1 month
Secondary Outcome Measures
NameTimeMethod
it checks the further deterioration of nightblindness, reduced peripheral visual field and blurredness of vision.1 month

Trial Locations

Locations (1)

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

🇮🇳

Hassan, KARNATAKA, India

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
🇮🇳Hassan, KARNATAKA, India
Dr Pushpa Raj Poudel
Principal investigator
9035906765
pundanraj@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.